Understanding Behaviour Through Medication Changes in PBS: Linking Presentation, Side Effects and Support

May 12, 2026

Positive Behaviour Support requires services to understand how medication changes may affect behaviour, presentation and daily coping. The Positive Behaviour Support knowledge hub supports providers to connect behaviour, communication, proactive support, rights and reduction of restrictive practice.

In specialist services, understanding behaviour through PBS means asking whether new medication, dosage changes, missed doses, side effects, withdrawal effects or PRN use may be influencing what staff see.

This reflects PBS principles and values, because behaviour should not be treated in isolation from health, comfort and wellbeing. Strong services observe carefully, escalate concerns appropriately and avoid using medication as a substitute for proactive support.

Concept Explained Clearly

Medication can affect behaviour through changes in alertness, sleep, appetite, movement, mood, anxiety, pain, concentration or physical comfort. A person may become more withdrawn, restless, irritable, tired, disinhibited or distressed after a medication change. They may also struggle if medication is delayed, refused or taken at a time that affects routines.

Understanding medication-related behaviour does not mean staff make clinical decisions outside their role. It means staff observe accurately, record changes, follow medication procedures and share evidence with prescribers. PBS teams need to understand how medication effects interact with environment, communication, routine and support approach.

Why It Matters in Real Services

When medication factors are missed, behaviour may be wrongly attributed to personality, motivation or risk. Staff may increase behavioural controls when the person is experiencing side effects, sedation, agitation or discomfort. This can lead to avoidable escalation and poor-quality support.

There are also safety and governance risks. Medication changes must be monitored, especially where people have limited verbal communication or complex needs. Commissioners and CQC will expect providers to evidence safe medication practice, appropriate escalation and person-centred behaviour support that does not rely on chemical restraint.

What Good Looks Like

Strong services demonstrate that medication changes are linked to behaviour monitoring. Staff know when medication has changed, what side effects to observe, what the person’s usual presentation is, and when concerns must be escalated.

Good PBS practice combines daily observation with clinical communication. Records include sleep, appetite, mood, movement, alertness, incidents, refusals, PRN use and quality-of-life impact. Providers should be able to evidence how behaviour, medication information, staff action and outcomes are connected.

Operational Example 1: Increased Agitation After Dose Change

Step 1 – Change noticed: A person in supported living became more restless and irritable after a medication dose was increased. Staff recorded more pacing, shorter tolerance of conversation and increased refusal of evening routines.

Step 2 – Pattern checked: The provider reviewed medication records, incident notes, sleep patterns and staff observations. The timing of behaviour change closely followed the dosage change.

Step 3 – Support adapted: Staff reduced non-essential evening demands, offered quieter routines and recorded specific changes in mood, movement and sleep rather than using vague terms such as “agitated.”

Step 4 – Clinical route used: The manager shared structured observations with the prescriber and requested review. Family feedback was also gathered to compare presentation across settings.

Step 5 – Evidence and outcome: After clinical review, the medication plan was adjusted and evening routines stabilised. The provider evidenced that behaviour change was monitored, escalated and understood safely.

Deepening the Understanding: Medication Monitoring Must Include Quality of Life

Medication monitoring should not focus only on whether incidents reduce. A person may have fewer incidents because they are sedated, withdrawn or less able to participate. Strong PBS services review whether medication supports wellbeing, communication, engagement and rights.

Providers should be able to evidence that medication is considered alongside proactive support. If a person needs environmental changes, better communication or pain review, medication alone should not become the answer. Behaviour records should help clinical colleagues make informed decisions, not replace clinical judgement.

The related guidance on seeing behaviour as communication in PBS reinforces why changes in presentation should be heard as information about health, support and unmet need.

Operational Example 2: Sedation Reducing Participation

Step 1 – Concern raised: In a residential service, a person appeared calmer after a medication change, but staff noticed they slept more during the day and stopped attending preferred activities.

Step 2 – Wider impact reviewed: The team looked beyond incident reduction. Records showed fewer episodes of shouting, but also reduced appetite, less conversation and lower engagement.

Step 3 – PBS response: Staff recorded alertness, activity participation, meals, mood and sleep across the day. They adjusted activity timing to when the person was most awake while clinical review was pending.

Step 4 – Governance action: The provider escalated concerns to the prescriber and reviewed whether the change was improving quality of life or simply reducing visible behaviour.

Step 5 – Evidence and outcome: The medication was reviewed and support routines were adjusted. Participation improved, and the provider evidenced that quality of life was part of medication monitoring.

Systems, Workforce and Consistency

Medication-related behaviour understanding must be shared across shifts. Staff need to know when medication has changed, what to observe, how to record it and who to escalate to. This should be included in handovers, medication communication records, PBS reviews and supervision.

Managers should check that staff are not making informal assumptions. A staff member may say “they are worse today,” but governance requires observable evidence: sleep, appetite, movement, engagement, mood, incidents and timing. Supervision should reinforce the boundary between observation and clinical decision-making.

Operational Example 3: PRN Use Masking Environmental Triggers

Step 1 – Practice reviewed: A person in a specialist service received PRN medication several times after distress during noisy evening periods. Incident reports focused on successful calming after PRN use.

Step 2 – Context analysed: The provider reviewed the events and found that distress usually occurred when the lounge was crowded, television volume was high and staff were busy with shift tasks.

Step 3 – Proactive support strengthened: Staff introduced a quieter evening option, reduced background noise and offered a sensory routine before the usual escalation window.

Step 4 – Medication governance checked: PRN use was reviewed with the prescriber and manager. Staff were reminded that PRN must not replace proactive environmental support.

Step 5 – Evidence and outcome: PRN use reduced, evening distress decreased and records showed more consistent use of sensory and environmental strategies. This created a clear line of sight from behaviour context to proactive action and reduced medication reliance.

Governance and Evidence

Governance should show how medication changes and behaviour are reviewed together. Providers should be able to evidence medication records, behaviour data, staff observations, PRN audits, clinical escalation, PBS plan updates, supervision notes and outcome monitoring.

Strong governance connects behaviour to health, support and quality of life. Records should show what changed, when it changed, what staff observed, what was escalated and what outcome followed. This creates a clear line of sight from behaviour to medication-related concern, from concern to action, and from action to outcome.

Commissioner and CQC Expectations

Commissioners expect providers to understand medication-related behaviour because it affects safety, rights and stability. They need assurance that providers monitor presentation carefully and do not rely on medication where proactive support should be strengthened.

CQC will expect safe medicines management, person-centred care and effective oversight. Inspectors may review whether staff monitor side effects, whether PRN use is governed, whether concerns are escalated and whether behaviour support remains proactive. Strong services demonstrate that medication is reviewed within wider PBS governance.

Common Pitfalls

Recording behaviour change without checking recent medication changes.
Assuming fewer incidents always mean improved wellbeing.
Using vague observations that do not help prescribers review medication safely.
Allowing PRN use to replace environmental, communication or sensory support.
Failing to monitor sleep, appetite, alertness and participation after medication changes.
Not updating PBS plans when medication-related patterns are identified.

Conclusion

Understanding behaviour through medication changes helps PBS teams link presentation, health, support and quality of life. Behaviour may show side effects, discomfort, sedation, agitation or the need for clinical review.

Strong providers observe carefully, record accurately and escalate through the right clinical routes. They also protect PBS principles by ensuring medication does not replace proactive, person-centred support. This gives commissioners and CQC clear evidence that behaviour, medication and outcomes are governed safely.